Steward Partners Investment Advisory LLC Reduces Position in Globe Life Inc. $GL

Steward Partners Investment Advisory LLC reduced its holdings in Globe Life Inc. (NYSE:GL) by 8.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,880 shares of the company’s stock after selling 2,034 shares during the period. Steward Partners Investment Advisory LLC’s holdings in Globe Life were worth $2,844,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently bought and sold shares of the business. Geode Capital Management LLC lifted its stake in Globe Life by 2.9% in the 2nd quarter. Geode Capital Management LLC now owns 2,722,768 shares of the company’s stock worth $339,875,000 after purchasing an additional 76,995 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in Globe Life by 9.3% during the first quarter. Dimensional Fund Advisors LP now owns 1,741,131 shares of the company’s stock worth $229,323,000 after buying an additional 148,397 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in Globe Life by 3.6% during the second quarter. Bank of New York Mellon Corp now owns 1,248,025 shares of the company’s stock worth $155,117,000 after buying an additional 43,095 shares during the last quarter. Jacobs Levy Equity Management Inc. grew its holdings in Globe Life by 35.9% in the 1st quarter. Jacobs Levy Equity Management Inc. now owns 1,025,984 shares of the company’s stock valued at $135,143,000 after buying an additional 271,253 shares in the last quarter. Finally, Nuveen LLC acquired a new stake in shares of Globe Life in the 1st quarter worth $131,608,000. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Globe Life Price Performance

Shares of GL opened at $134.73 on Friday. The firm has a 50-day simple moving average of $135.67 and a two-hundred day simple moving average of $131.55. The stock has a market cap of $10.73 billion, a PE ratio of 9.76 and a beta of 0.55. Globe Life Inc. has a 1-year low of $100.27 and a 1-year high of $147.83. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.06 and a quick ratio of 0.06.

Globe Life (NYSE:GL) last posted its quarterly earnings data on Wednesday, October 22nd. The company reported $4.81 earnings per share for the quarter, topping analysts’ consensus estimates of $4.54 by $0.27. Globe Life had a net margin of 19.36% and a return on equity of 22.12%. The firm had revenue of $1.51 billion during the quarter, compared to analysts’ expectations of $1.52 billion. During the same quarter last year, the company posted $3.44 EPS. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS. FY 2025 guidance at 14.400-14.600 EPS. As a group, analysts forecast that Globe Life Inc. will post 13.87 EPS for the current year.

Globe Life Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Monday, January 5th will be paid a $0.27 dividend. The ex-dividend date of this dividend is Monday, January 5th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.8%. Globe Life’s payout ratio is presently 7.83%.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on GL. Truist Financial boosted their price target on shares of Globe Life from $150.00 to $158.00 and gave the company a “buy” rating in a research report on Friday, October 24th. Keefe, Bruyette & Woods boosted their target price on shares of Globe Life from $160.00 to $162.00 and gave the company an “outperform” rating in a report on Tuesday, October 28th. Piper Sandler reissued an “overweight” rating and issued a $167.00 price target on shares of Globe Life in a research note on Friday, November 21st. Morgan Stanley reduced their price target on shares of Globe Life from $179.00 to $177.00 and set an “overweight” rating on the stock in a research report on Monday, November 17th. Finally, Wells Fargo & Company decreased their price objective on Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a report on Friday, October 24th. Seven research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $155.56.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.